LL-37 boosts immunosuppressive function of placenta-derived mesenchymal stromal cells

BACKGROUND: Although promising for graft-versus-host disease (GvHD) treatment, MSC therapy still faces important challenges. For instance, increasing MSC migratory capacity as well as potentializing immune response suppression are of interest. For GvHD management, preventing opportunistic infections...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira-Bravo, Martha, Sangiorgi, Bruno Braga, Schiavinato, Josiane Lilian dos Santos, Carvalho, Juliana Lott, Covas, Dimas Tadeu, Panepucci, Rodrigo Alexandre, Neves, Francisco de Assis Rocha, Franco, Octávio Luiz, Pereira, Rinaldo Wellerson, Saldanha-Araujo, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203704/
https://www.ncbi.nlm.nih.gov/pubmed/28038684
http://dx.doi.org/10.1186/s13287-016-0448-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203704/
https://www.ncbi.nlm.nih.gov/pubmed/28038684
http://dx.doi.org/10.1186/s13287-016-0448-3

Ejemplares similares